Title of article :
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
Author/Authors :
John A. Ormiston، نويسنده , , Patrick W Serruys، نويسنده , , Evelyn Regar، نويسنده , , Dariusz Dudek، نويسنده , , Leif Thuesen، نويسنده , , Mark W.I. Webster، نويسنده , , Yoshinobu Onuma، نويسنده , , Hector M Garcia-Garcia، نويسنده , , Robert McGreevy، نويسنده , , Susan Veldhof، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2008
Pages :
9
From page :
899
To page :
907
Abstract :
Background A fully bioabsorbable drug-eluting coronary stent that scaffolds the vessel wall when needed and then disappears once the acute recoil and constrictive remodelling processes have subsided has theoretical advantages. The bioasorbable everolimus-
Journal title :
The Lancet
Serial Year :
2008
Journal title :
The Lancet
Record number :
592627
Link To Document :
https://search.isc.ac/dl/search/defaultta.aspx?DTC=10&DC=592627
بازگشت